Evidence map›Paper›PMID 37464051›Full record

ArticleNature immunology2023

Author Correction: Neoantigen-specific stem cell memory-like CD4

Spencer E Brightman, Angelica Becker, Rukman R Thota, Martin S Naradikian, Leila Chihab, Karla Soria Zavala, Ashmitaa Logandha Ramamoorthy Premlal, Ryan Q Griswold, Joseph S Dolina, Ezra E W Cohen and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Spencer E BrightmanDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.
Angelica BeckerDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.
Rukman R ThotaDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-9225-9516
Martin S NaradikianDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.
Leila ChihabDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA.
Karla Soria ZavalaDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.
Ashmitaa Logandha Ramamoorthy PremlalDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA.
Ryan Q GriswoldDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.
Joseph S DolinaDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.
Ezra E W CohenDivision of Hematology and Oncology, University of California San Diego Moores Cancer Center, UCSD, La Jolla, CA, USA.
Aaron M MillerDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.
Bjoern PetersDivision of Hematology and Oncology, University of California San Diego Moores Cancer Center, UCSD, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-8457-6693
Stephen P SchoenbergerDivision of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA. sps@lji.org.ORCID http://orcid.org/0000-0002-9870-7340

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37464051
PMCPMC10382305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.